Dr. Barbara Hutchinson is Medical Director of Flourish Bowie. She earned her undergraduate degree from the University of the West Indies in Trinidad in Chemistry and Biochemistry. She migrated to the US and completed a PhD in Cardiovascular Pharmacology at Howard University, Washington DC before going to the University of Maryland Medical School, Baltimore MD where she completed her medical degree. She went on to complete her Internal Medicine Residency and Cardiology Fellowship at the University of Maryland Medical Center in Baltimore Maryland. She is certified in both Cardiovascular Medicine and Sleep Medicine by the American Board of Internal Medicine.
Dr. Hutchinson is the President and managing partner of Chesapeake Cardiac Care providing cardiovascular and sleep care in Bowie Maryland. She is a fellow of the American College of Cardiology, member of American Academy of Cardiovascular Sleep Medicine, Past President of the Association of Black Cardiologist and currently sits on several medical advisory and non-profit boards.
Dr. Hutchinson has been involved in clinical trials for over 30 years serving as clinical research coordinator, Sub-Investigator and Principal Investigator. Areas of clinical research have included congestive heart failure, hyperlipidemia, atrial fibrillation, hypertension, myocardial infarction, and coronary artery disease. She has several publications and has presented both nationally and internationally on cardiovascular disease and sleep.
Dr. Hutchinson is passionate about bridging the gap in clinical trials to ensure that study populations reflect real-world population for drugs and devices, by being intentional about inclusion of underrepresented groups in all facets of clinical research.
The American Heart Association of Baltimore & Greater Maryland selected Dr. Barbara Hutchinson as the recipient of the 2023 Watkins-Saunders Award.
Contact us about your next trial at email@example.com.
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.